Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-18 12:10 pm Purchase |
2025-06-30 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
203,017 1.600% |
203,017 (New Position) |
Filing History |
| 2025-07-09 4:39 pm Purchase |
2025-07-01 | 13G | Nektar Therapeutics NKTR |
BIOTECHNOLOGY VALUE FUND L P | 1,276,595 7.400% |
1,276,595 (New Position) |
Filing History |
| 2025-07-03 2:07 pm Purchase |
2025-06-27 | 13G | Nektar Therapeutics NKTR |
Integrated Core Strategies (US) LLC | 932,863 5.400% |
932,863 (New Position) |
Filing History |
| 2025-05-15 3:35 pm Sale |
2025-03-31 | 13G | Nektar Therapeutics NKTR |
SAMLYN CAPITAL LLC | 0 0.000% |
-644,470 (Position Closed) |
Filing History |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
835,200 6.700% |
-229,423 (-21.55%) |
Filing History |
| 2025-02-14 1:49 pm Purchase |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
SAMLYN CAPITAL LLC | 644,470 5.200% |
644,470 (New Position) |
Filing History |
| 2025-02-14 12:08 pm Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
EVENTIDE ASSET MANAGEMENT LLC | 443,333 3.610% |
-183,333 (-29.26%) |
Filing History |
| 2025-02-14 08:43 am Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 131,733 1.070% |
-929,777 (-87.59%) |
Filing History |
| 2024-11-14 12:17 pm Purchase |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
EVENTIDE ASSET MANAGEMENT LLC | 626,667 5.110% |
626,667 (New Position) |
Filing History |
| 2024-11-14 09:18 am Sale |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 1,061,510 8.650% |
-165,156 (-13.46%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
1,064,623 8.700% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
BlackRock Inc. BLK |
1,064,623 8.700% |
491,002 (+85.60%) |
Filing History |
| 2024-03-15 4:18 pm Purchase |
2024-03-06 | 13G | Nektar Therapeutics NKTR |
TCG Crossover GP II, LLC | 1,336,423 9.900% |
1,336,423 (New Position) |
Filing History |
| 2024-02-14 5:03 pm Sale |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
RA Capital Management, L.P. | 0 0.000% |
-1,246,667 (Position Closed) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
Citadel Advisors LLC | 375,675 3.000% |
-272,975 (-42.08%) |
Filing History |
| 2024-02-14 08:50 am Purchase |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 1,226,667 9.650% |
406,518 (+49.57%) |
Filing History |
| 2024-02-13 5:09 pm Sale |
2023-12-29 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 802,858 6.310% |
-888 (-0.11%) |
Filing History |
| 2023-08-17 4:30 pm Purchase |
2023-08-07 | 13G | Nektar Therapeutics NKTR |
RA Capital Management, L.P. | 1,246,667 9.800% |
1,246,667 (New Position) |
Filing History |
| 2023-07-10 2:09 pm Sale |
2023-07-10 | 13G | Nektar Therapeutics NKTR |
Invesco Ltd. IVZ |
369,029 2.900% |
-2,119,470 (-85.17%) |
Filing History |
| 2023-07-10 10:41 am Sale |
2023-06-30 | 13G | Nektar Therapeutics NKTR |
The Vanguard Group | 803,746 6.370% |
-733,973 (-47.73%) |
Filing History |